Women were less likely than men to be treated for relapsing multiple sclerosis (MS), French registry data showed. Women had a ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Data from the HERCULES trial presented at the ECTRIMS conference in Copenhagen, Denmark, today showed that tolebrutinib was ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...

TANZANIA is set to host the 11th Asia-Africa Luminaries Conference, organised by the Merck Foundation, focusing on health ...

Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...

CorriXR Therapeutics, Inc. ("CorriXR"), a biotherapeutics company developing unique genetic medicines that optimize the effectiveness of existing cancer treatments by knocking out genes responsible ...

A short course of Mavenclad can provide long-term reductions in disease activity and disability progression in highly active ...

Nestled in verdant greenery, the innovation hub’s like-minded community, customisable workspaces and proximity to key ...

Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...